Nucleation capacity and presence of centrioles define a distinct category of centrosome abnormalities that induces multipolar mitoses in cancer cells

Analysis of centrosome number and structure has become one means of assessing the potential for aberrant chromosome segregation and aneuploidy in tumor cells. Centrosome amplification directly causes multipolar catastrophic mitoses in mouse embryonic fibroblasts (MEFs) deficient for the tumor suppressor genes Brca1 or Trp53. We observed supernumerary centrosomes in cell lines established from aneuploid, but not from diploid, colorectal carcinomas; however, multipolar mitoses were never observed. This discrepancy prompted us to thoroughly characterize the centrosome abnormalities in these and other cancer cell lines with respect to both structure and function. The most striking result was that supernumerary centrosomes in aneuploid colorectal cancer cell lines were unable to nucleate microtubules, despite the presence of γ‐tubulin, pericentrin, PLK1, and AURKA. Analysis by scanning electron microscopy revealed that these supernumerary structures are devoid of centrioles, a result significantly different from observations in aneuploid pancreatic cancer cell lines and in Trp53 or Brca1 deficient MEFs. Thus, multipolar mitoses are dependent upon the ability of extra γ‐tubulin containing structures to nucleate microtubules, and this correlated with the presence of centrioles. The assessment of centrosome function with respect to chromosome segregation must therefore take into consideration the presence of centrioles and the capacity to nucleate microtubules. The patterns and mechanisms of chromosomal aberrations in hematologic malignancies and solid tumors are fundamentally different. The former is characterized by specific chromosome translocations, whose consequence is the activation of oncogenes. Most carcinomas, however, reveal variations in the nuclear DNA content. The observed genomic imbalances and gross variations in chromosome number can result from unequal chromosome segregation during mitotic cell division. It is therefore fundamental to elucidate mechanisms involved in distribution of the genome to daughter cells. Prior to cell division, the centrosome organizes microtubules and the mitotic spindle. Deciphering the consequences of alterations in centrosome number, structure, and function is an important step towards understanding how a diploid genome is maintained. Although extra centrosomes have now been observed in carcinomas and were correlated with aneuploidy, a careful functional investigation of these structures and their role in generating chromosome imbalances may lead to the identification of distinct mechanistic pathways of genomic instability. Understanding these pathways will also be important in determining whether they are potential molecular targets of therapeutic intervention. Environ. Mol. Mutagen., 2009. © 2009 Wiley‐Liss, Inc.

[1]  Martin Dufva,et al.  Introduction to Microarray Technology , 2018, Predictive Biomarkers in Oncology.

[2]  T. Ried,et al.  Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer , 2009, Genes, chromosomes & cancer.

[3]  T. Ried Homage to Theodor Boveri (1862–1915): Boveri's theory of cancer as a disease of the chromosomes, and the landscape of genomic imbalances in human carcinomas , 2009, Environmental and molecular mutagenesis.

[4]  J. Lundeberg,et al.  Generations of sequencing technologies. , 2009, Genomics.

[5]  R. Uzbekov,et al.  The centrosome is a polyfunctional multiprotein cell complex , 2008, Biochemistry (Moscow).

[6]  Yidong Chen,et al.  Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome. , 2008, Cancer research.

[7]  D. Forbes,et al.  Centrin 2 Localizes to the Vertebrate Nuclear Pore and Plays a Role in mRNA and Protein Export , 2008, Molecular and Cellular Biology.

[8]  Jan-Michael Peters,et al.  Polo-like kinase 1 triggers the initiation of cytokinesis in human cells by promoting recruitment of the RhoGEF Ect2 to the central spindle. , 2007, Developmental cell.

[9]  U. Klein,et al.  Cooperation between Mitotic Kinesins Controls the Late Stages of Cytokinesis , 2006, Current Biology.

[10]  K. Sugasawa,et al.  Centrin 2 Stimulates Nucleotide Excision Repair by Interacting with Xeroderma Pigmentosum Group C Protein , 2005, Molecular and Cellular Biology.

[11]  J. Delabie,et al.  Identification of a novel centrosome/microtubule-associated coiled-coil protein involved in cell-cycle progression and spindle organization , 2005, Oncogene.

[12]  B. Bowerman Cell division: Timing the machine , 2004, Nature.

[13]  J. Maller,et al.  A Feedback Loop in the Polo-like Kinase Activation Pathway* , 2004, Journal of Biological Chemistry.

[14]  G. C. Rogers,et al.  Two mitotic kinesins cooperate to drive sister chromatid separation during anaphase , 2004, Nature.

[15]  A. Popescu,et al.  Xeroderma Pigmentosum Group C Protein Possesses a High Affinity Binding Site to Human Centrin 2 and Calmodulin* , 2003, Journal of Biological Chemistry.

[16]  E. Karsenti,et al.  XMAP215 Is Required for the Microtubule-Nucleating Activity of Centrosomes , 2002, Current Biology.

[17]  C. Deng,et al.  Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer , 2002, Oncogene.

[18]  D. Agard,et al.  GCP5 and GCP6: two new members of the human gamma-tubulin complex. , 2001, Molecular biology of the cell.

[19]  T. Stearns,et al.  Centrosome Duplication A Centriolar Pas de Deux , 2001, Cell.

[20]  C. Rieder,et al.  Centrosomes Enhance the Fidelity of Cytokinesis in Vertebrates and Are Required for Cell Cycle Progression , 2001, The Journal of cell biology.

[21]  Y. A. Minamishima,et al.  Correlation between centrosome abnormalities and chromosomal instability in human pancreatic cancer cells. , 2001, Cancer genetics and cytogenetics.

[22]  Jun Sano,et al.  Centrosomal Kinases, HsAIRK1 and HsAIRK3, are Overexpressed in Primary Colorectal Cancers , 2000, Japanese journal of cancer research : Gann.

[23]  E. Schröck,et al.  Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations , 2000, Genes, chromosomes & cancer.

[24]  G. Pihan,et al.  The mitotic machinery as a source of genetic instability in cancer. , 1999, Seminars in cancer biology.

[25]  E. Schröck,et al.  Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: A phenotype/genotype correlation , 1999, Genes, chromosomes & cancer.

[26]  D. Longo,et al.  Association of polo-like kinase with alpha-, beta- and gamma-tubulins in a stable complex. , 1999, The Biochemical journal.

[27]  X. Wang,et al.  Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. , 1999, Molecular cell.

[28]  J. Maller,et al.  Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. , 1999, Science.

[29]  K. Kinzler,et al.  Genetic instabilities in human cancers , 1998, Nature.

[30]  J. Maller,et al.  Purification and cloning of a protein kinase that phosphorylates and activates the polo-like kinase Plx1. , 1998, Science.

[31]  K. Kinzler,et al.  Requirement for p53 and p21 to sustain G2 arrest after DNA damage. , 1998, Science.

[32]  Jian Kuang,et al.  Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation , 1998, Nature Genetics.

[33]  H Knecht,et al.  Centrosome defects and genetic instability in malignant tumors. , 1998, Cancer research.

[34]  S. Schwartz,et al.  Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53 , 1998, Oncogene.

[35]  J. Maller,et al.  Activated Polo-Like Kinase Plx1 Is Required at Multiple Points during Mitosis in Xenopus laevis , 1998, Molecular and Cellular Biology.

[36]  N. Lawrence,et al.  Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle , 1998, Medicinal research reviews.

[37]  Brian Schryver,et al.  A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers , 1998, The EMBO journal.

[38]  J. Ingle,et al.  Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  H. Lane,et al.  Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes , 1996, The Journal of cell biology.

[40]  D. Ledbetter,et al.  Multicolor Spectral Karyotyping of Human Chromosomes , 1996, Science.

[41]  Bert Vogelstein,et al.  Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21 , 1996, Nature.

[42]  G. Woude,et al.  Abnormal Centrosome Amplification in the Absence of p53 , 1996, Science.

[43]  B. Alberts,et al.  Microtubule nucleation by γ-tubulin-containing rings in the centrosome , 1995, Nature.

[44]  D. Longo,et al.  Polo-like Kinase Is a Cell Cycle-regulated Kinase Activated during Mitosis (*) , 1995, The Journal of Biological Chemistry.

[45]  G. Géraud,et al.  Polar organization of gamma-tubulin in acentriolar mitotic spindles of Drosophila melanogaster cells. , 1995, Journal of cell science.

[46]  D. Glover,et al.  Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles , 1995, Cell.

[47]  M. Kirschner,et al.  Pericentrin, a highly conserved centrosome protein involved in microtubule organization , 1994, Cell.

[48]  D. Sudar,et al.  Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. , 1992, Science.

[49]  K. Nagashima,et al.  Ultrastructural studies of surface features of human normal and tumor cells in tissue culture by scanning and transmission electron microscopy. , 1976, Journal of the National Cancer Institute.

[50]  B. Brinkley,et al.  Managing the centrosome numbers game: from chaos to stability in cancer cell division. , 2001, Trends in cell biology.

[51]  B. Brinkley,et al.  Supernumerary centrosomes and cancer: Boveri's hypothesis resurrected. , 1998, Cell motility and the cytoskeleton.

[52]  T. Stearns,et al.  Centrosomal deployment of gamma-tubulin and pericentrin: evidence for a microtubule-nucleating domain and a minus-end docking domain in certain mouse epithelial cells. , 1997, Cell motility and the cytoskeleton.

[53]  J. Salisbury Centrin, centrosomes, and mitotic spindle poles. , 1995, Current opinion in cell biology.